Reverting to a Healthy Diet during Lactation Normalizes Maternal Milk Lipid Content of Diet-Induced Obese Rats and Prevents Early Alterations in the Plasma Lipidome of the Offspring.


Journal

Molecular nutrition & food research
ISSN: 1613-4133
Titre abrégé: Mol Nutr Food Res
Pays: Germany
ID NLM: 101231818

Informations de publication

Date de publication:
09 2022
Historique:
revised: 25 05 2022
received: 30 03 2022
pubmed: 1 7 2022
medline: 9 9 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

This study aims to assess in rats whether normalizing maternal diet during lactation prevents the harmful effects of western diet (WD) consumption during the whole perinatal period on the lipidomic profile in maternal milk and offspring plasma. Control dams (CON-dams), fed with standard diet (SD); WD-dams, fed with WD prior and during gestation and lactation; and reversion dams (REV-dams), fed as WD-dams but moved to SD during lactation are followed. Lipidomic analysis is performed in milk and plasma samples from pups. Milk of WD-dams presents a different triacylglycerol composition and free fatty acid (FA) profile compared to CON-dams, including an increased ratio of pro-inflammatory to anti-inflammatory long-chain polyunsaturated FA. Such alterations, which are also present in the plasma of their offspring, are widely reversed in the milk of REV-dams and the plasma of their pups. This is related with the recovery of control adiponectin expression levels in the mammary gland, and the presence of decreased expression of pro-inflammatory factors. Implementing a healthy diet during lactation prevents early alterations in the plasma lipidome of pups associated to the maternal intake of an obesogenic diet, which may be related to the normalization of milk lipid content and the inflammatory state in the mammary gland.

Identifiants

pubmed: 35772018
doi: 10.1002/mnfr.202200204
pmc: PMC9541142
doi:

Substances chimiques

Fatty Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200204

Informations de copyright

© 2022 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH GmbH.

Références

Anaesthesia. 2000 May;55(5):442-9
pubmed: 10792135
Eur J Clin Nutr. 2016 Feb;70(2):250-6
pubmed: 26419197
Adv Exp Med Biol. 2001;501:169-77
pubmed: 11787680
Int J Obes (Lond). 2017 Aug;41(8):1279-1287
pubmed: 28190874
Eur J Clin Invest. 2021 May;51(5):e13482
pubmed: 33350459
J Dev Orig Health Dis. 2018 Jun;9(3):266-269
pubmed: 28870276
Proc Nutr Soc. 2006 Feb;65(1):97-105
pubmed: 16441949
Mol Nutr Food Res. 2019 Oct;63(20):e1900504
pubmed: 31419033
Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E114-20
pubmed: 18957619
J Nutr Biochem. 2022 Sep;107:109043
pubmed: 35569798
Br J Nutr. 2016 Feb 14;115(3):538-46
pubmed: 26608475
Indian Pediatr. 2009 Sep;46(9):785-90
pubmed: 19812424
J Biol Chem. 2004 Jun 4;279(23):23942-52
pubmed: 15028733
Nutr Diabetes. 2018 Apr 25;8(1):18
pubmed: 29695710
Annu Rev Nutr. 2005;25:549-71
pubmed: 16011478
Biochem Mol Biol Int. 1996 Oct;40(2):295-303
pubmed: 8896751
Int J Obes (Lond). 2017 Apr;41(4):510-517
pubmed: 27876761
Breastfeed Med. 2017 Nov;12(9):517-527
pubmed: 28880568
Eur J Pediatr. 2010 Feb;169(2):149-64
pubmed: 19672626
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158556
pubmed: 31678620
Kidney Res Clin Pract. 2015 Dec;34(4):194-200
pubmed: 26779421
Int J Mol Sci. 2020 Jul 30;21(15):
pubmed: 32751478
FASEB J. 2017 May;31(5):2037-2049
pubmed: 28167496
Mol Nutr Food Res. 2022 Sep;66(17):e2200204
pubmed: 35772018
Taiwan J Obstet Gynecol. 2017 Apr;56(2):133-138
pubmed: 28420495
Best Pract Res Clin Endocrinol Metab. 2012 Oct;26(5):641-53
pubmed: 22980046
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396
pubmed: 34019663
Annu Rev Nutr. 1997;17:159-83
pubmed: 9240924
Nutrients. 2020 Dec 30;13(1):
pubmed: 33396781
J Dairy Res. 2005 Nov;72(4):460-9
pubmed: 16223462
Prog Lipid Res. 2001 Jan-Mar;40(1-2):1-94
pubmed: 11137568
Endocrinology. 2015 Apr;156(4):1504-13
pubmed: 25590242
Am J Clin Nutr. 2016 Sep;104(3):646-62
pubmed: 27534637
Am J Clin Nutr. 2014 Mar;99(3):734S-41S
pubmed: 24500153
J Nutr. 1999 Aug;129(8):1574-8
pubmed: 10419993
Early Hum Dev. 2007 Dec;83(12):761-6
pubmed: 17920214
Nat Biotechnol. 2020 Oct;38(10):1159-1163
pubmed: 32541957
J Dairy Sci. 1980 Feb;63(2):337-52
pubmed: 6102100
Arch Med Res. 2016 Jan;47(1):1-12
pubmed: 26827819
PLoS One. 2014 May 21;9(5):e98066
pubmed: 24849657
BMC Med. 2005 Jun 23;3:11
pubmed: 15975147
Front Physiol. 2012 Nov 22;3:436
pubmed: 23189059
Endocrinology. 1999 Mar;140(3):1089-93
pubmed: 10067830
J Physiol. 2010 May 15;588(Pt 10):1791-9
pubmed: 20351043
Obesity (Silver Spring). 2012 Jan;20(1):65-75
pubmed: 21720435
Int J Obes (Lond). 2022 Jan;46(1):39-49
pubmed: 34475504

Auteurs

Pedro Castillo (P)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics, Biomarkers and Risk Evaluation) of the University of the Balearic Islands, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Health Research Institute of the Balearic Islands (IdISBa), Palma, 07122, Spain.

Ondrej Kuda (O)

Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, Prague, 14220, Czech Republic.

Jan Kopecky (J)

Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, Prague, 14220, Czech Republic.

Catalina Amadora Pomar (CA)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics, Biomarkers and Risk Evaluation) of the University of the Balearic Islands, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Health Research Institute of the Balearic Islands (IdISBa), Palma, 07122, Spain.

Andreu Palou (A)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics, Biomarkers and Risk Evaluation) of the University of the Balearic Islands, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Health Research Institute of the Balearic Islands (IdISBa), Palma, 07122, Spain.

Mariona Palou (M)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics, Biomarkers and Risk Evaluation) of the University of the Balearic Islands, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Health Research Institute of the Balearic Islands (IdISBa), Palma, 07122, Spain.

Catalina Picó (C)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics, Biomarkers and Risk Evaluation) of the University of the Balearic Islands, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Health Research Institute of the Balearic Islands (IdISBa), Palma, 07122, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH